JPS60209530A - 殺腫瘍性物質 - Google Patents

殺腫瘍性物質

Info

Publication number
JPS60209530A
JPS60209530A JP59066330A JP6633084A JPS60209530A JP S60209530 A JPS60209530 A JP S60209530A JP 59066330 A JP59066330 A JP 59066330A JP 6633084 A JP6633084 A JP 6633084A JP S60209530 A JPS60209530 A JP S60209530A
Authority
JP
Japan
Prior art keywords
molecular weight
substance
activity
originated
lectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59066330A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0144199B2 (enExample
Inventor
Shunji Natori
俊二 名取
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Teijin Ltd
Tanabe Pharma Corp
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Teijin Ltd
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd, Teijin Ltd, Yoshitomi Pharmaceutical Industries Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Priority to JP59066330A priority Critical patent/JPS60209530A/ja
Publication of JPS60209530A publication Critical patent/JPS60209530A/ja
Publication of JPH0144199B2 publication Critical patent/JPH0144199B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP59066330A 1984-04-02 1984-04-02 殺腫瘍性物質 Granted JPS60209530A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59066330A JPS60209530A (ja) 1984-04-02 1984-04-02 殺腫瘍性物質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59066330A JPS60209530A (ja) 1984-04-02 1984-04-02 殺腫瘍性物質

Publications (2)

Publication Number Publication Date
JPS60209530A true JPS60209530A (ja) 1985-10-22
JPH0144199B2 JPH0144199B2 (enExample) 1989-09-26

Family

ID=13312723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59066330A Granted JPS60209530A (ja) 1984-04-02 1984-04-02 殺腫瘍性物質

Country Status (1)

Country Link
JP (1) JPS60209530A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6377900A (ja) * 1986-09-18 1988-04-08 Sanwa Kagaku Kenkyusho Co Ltd ヤママユガ由来のレクチン様物質及びその分離精製法並びにその用途
US4960756A (en) * 1986-09-13 1990-10-02 Sanwa Kagaku Kenkyusho Co., Ltd. Lectin like protein substance, method of obtaining same and anti-tumor agent comprising same
JP2016053003A (ja) * 2014-09-03 2016-04-14 学校法人 東洋大学 カイガラムシ由来のポリペプチド

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960756A (en) * 1986-09-13 1990-10-02 Sanwa Kagaku Kenkyusho Co., Ltd. Lectin like protein substance, method of obtaining same and anti-tumor agent comprising same
JPS6377900A (ja) * 1986-09-18 1988-04-08 Sanwa Kagaku Kenkyusho Co Ltd ヤママユガ由来のレクチン様物質及びその分離精製法並びにその用途
JP2016053003A (ja) * 2014-09-03 2016-04-14 学校法人 東洋大学 カイガラムシ由来のポリペプチド

Also Published As

Publication number Publication date
JPH0144199B2 (enExample) 1989-09-26

Similar Documents

Publication Publication Date Title
US4464355A (en) Serum-free and mitogen-free T-cell growth factor and process for making same
US4390623A (en) Serum-free and mitogen-free T-cell growth factor and process for making same
JPS6156186A (ja) 生体処置方法，処置用化合物及びその製造方法
FR2522267A1 (fr) Glycoproteines a activite antitumorale, leur procede de preparation et leur application therapeutique
EP0049611B1 (en) A t-cell growth factor, and a process of producing the same
US6242255B1 (en) Protein which induces interferon-gamma production by immunocompetent cell
JPS6154040B2 (enExample)
JPS6019719A (ja) 抗腫瘍活性を有する蛋白質
JPS60209530A (ja) 殺腫瘍性物質
FI115383B (fi) Menetelmä Anti-inflammatorisen tekijän eristämiseksi
CA2058464A1 (en) Induction of tolerance with modified immunogens
JPH0296598A (ja) リンフォカイン活性化キラー細胞誘導抑制因子ｌａｋｓｆ，その製造法およびそれを有効成分とする免疫抑制剤
WO1984002912A1 (fr) Proteine a effet oncostatique, son procede de preparation et mediament oncostatique la contenant
JPH09500262A (ja) 毒素結合性バイオポリマーの製造、その使用
JPS63164895A (ja) 培養細胞由来のレクチン様蛋白質及びその製法並びに該物質を主成分とする抗腫瘍剤
EP0161384A2 (en) Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same
JPS60208924A (ja) ヒト腫瘍壊死因子に対する抗体
SU1412596A3 (ru) Способ получени цитотоксических к раковым клеткам лимфоцитов и способ получени гликосв занного антигена
JPH0214039B2 (enExample)
JPS6245208B2 (enExample)
FI77157C (fi) Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen.
NIITANI et al. Labilizing effect of lipoprotein lipase on lysosomes of tumor cells
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JPS6267026A (ja) 新リンホカインｉｉｉとその製法
KR890004692B1 (ko) 항종양 생리학적 활성물질의 정제방법